The iTClamp® by Innovative Trauma Care® represents the latest advance in battlefield hemorrhage control − the leading cause of preventable combat death. For self-aid or buddy-aid, it is an intuitive, easy to apply, combat-ready wound closure device that controls severe bleeding within seconds of application during “care under fire”.
Virtually painless, the iTClamp® seals the wound, creating localized, hands-free pressure that quickly forms a stable clot and prevents further blood loss. Localized pressure remains the simplest, time-tested way to control severe hemorrhage. Application of the iTClamp® is intuitive and with minimal training every warfighter can instantly treat life−threatening hemorrhage not amenable to a tourniquet.
No comparable product exists for “care under fire” or any situations where a tourniquet is not applicable. The iTClamp® is easy-to-use and can be applied in seconds with a one-handed squeeze application.
What makes the iTClamp different?:
- Fast: Applied in 10 seconds or less, published pre-clinical studies demonstrate the iTClamp®has a greater than 90% first try application success factor, with the lowest Mean Estimated Blood loss (120cc)1, and the longest Mean Survival Time (>180 minutes)1.
- Versatile: FDA-cleared for extremity, axillary, inguinal, scalp and neck wounds. The primary battlefield advantage is the ability to immediately confirm effective placement and rapidly readjust as required. If required, re-adjustment takes only seconds and allows the provider to confirm effective treatment before attending to other life threatening injuries or preparing for evacuation.
- Effective: 100% survival in lethal groin injury model.2 The iTClamp® is limited to wounds where skin edges can be approximated and only works in compressible areas of the body. Tourniquets are still required for amputations and hemostatic agents may still be needed to pack wounds with large cavities. The iTClamp® might not be the only device used to treat a wounded casualty but, in many cases, it should be the first one considered.